These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26467274)

  • 1. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
    Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
    Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
    J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
    Blake E; Allen J; Thorn C; Shore A; Curnow A
    Lasers Med Sci; 2013 May; 28(3):997-1005. PubMed ID: 22926533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.
    Smits T; van Laarhoven AI; Staassen A; van de Kerkhof PC; van Erp PE; Gerritsen MJ
    Br J Dermatol; 2009 Apr; 160(4):849-57. PubMed ID: 19175603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
    Tyrrell J; Campbell S; Curnow A
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):86-97. PubMed ID: 20510303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
    Nissen CV; Philipsen PA; Wulf HC
    Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?
    Wiegell SR; Lerche CM; Wulf HC
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):88-92. PubMed ID: 26577455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
    Tyrrell JS; Morton C; Campbell SM; Curnow A
    Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
    Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
    Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Br J Dermatol; 2017 May; 176(5):1241-1246. PubMed ID: 27696393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
    Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
    Lesar A; Ferguson J; Moseley H
    Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    Choudry K; Brooke RC; Farrar W; Rhodes LE
    Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
    de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
    Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
    J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.